TY - JOUR T1 - Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK JO - Osteoporosis International UR - http://dx.doi.org/10.1007/s00198-024-07251-w PY - 2024/10/04 AU - Borgstr枚m F AU - Lorentzon M AU - Johansson H AU - Harvey NC AU - McCloskey E AU - Willems D AU - Knutsson D AU - Kanis JA ED - DO - DOI: 10.1007/s00198-024-07251-w PB - Springer Science and Business Media LLC Y2 - 2025/06/21 ER -